🧭 Longevity in Dubai at a Glance

Dubai is moving longevity beyond the traditional luxury-wellness model.

In June 2026, Law No. 17 established the Dubai Longevity Authority (DLA).

The law's objectives include developing Dubai as a global hub for longevity and advanced therapeutic products while enabling approved preventive, regenerative, restorative and science-based health activities.¹

Dubai's government describes the DLA as a new regulator for the emirate's longevity, wellness and advanced-health sectors.²

For patients, that creates opportunity and complexity.

A single longevity program may combine conventional preventive medicine with VO₂max testing, biological-age assessments, genomics, hormones, NAD+ infusions, peptides or regenerative therapies.

Those services do not all have the same evidence behind them.

‍

🧬 What Is Longevity Medicine?

Longevity medicine aims to extend healthspan, meaning the years you remain healthy, functional and independent, rather than simply maximizing chronological lifespan.

At its best, longevity medicine is sophisticated preventive healthcare.

It asks practical questions: What are your largest modifiable risks?

What is beginning to change? Which interventions are most likely to matter? And what should be measured again over time?

The category becomes less clear when longevity is used to describe everything from blood-pressure control and exercise prescriptions to peptide injections, biological-age tests, whole-body MRI, IV therapies, supplements and stem-cell treatments.

It helps to separate four overlapping concepts.

Longevity medicine generally focuses on prevention, function, risk reduction and healthy aging.

Anti-aging medicine is a broader commercial term that can include medicine, aesthetics, hormones, supplements and experimental therapies.

Biohacking often involves self-directed health optimization. Some approaches are well grounded in conventional health science; others remain speculative.

Wellness can meaningfully improve quality of life without necessarily changing disease risk or aging biology.

The label matters less than what is actually being offered.

The useful question is:

What is this intervention supposed to improve, and how strong is the evidence that it can do so?

‍

🇦🇪 Why Is Dubai Becoming a Longevity Hub?

Dubai has moved longevity from a loosely defined wellness trend toward a formally recognized healthcare and economic sector.

Law No. 17 of 2026 established the DLA with objectives that include attracting longevity companies, research and talent; supporting approved science-based activities; enabling personalized health programs; and promoting safe preventive and therapeutic interventions.¹

The government has explicitly positioned the initiative around developing Dubai as a global hub for regulated longevity, wellness and advanced healthcare.²

Dubai already had many of the ingredients needed for that market: substantial private healthcare infrastructure, international patients, advanced diagnostics, premium hospitality and a rapidly expanding personalized and regenerative medicine ecosystem.

The 2026 development adds something more important: institutional direction and regulatory structure.

‍

🏛️ Who Regulates Longevity Medicine in Dubai?

There is no single regulator responsible for every element of a longevity program.

Different layers of oversight can apply depending on whether you are dealing with a healthcare facility, physician, medical product, investigational therapy or specialized treatment.

DHA describes its mandate as including the regulation, licensing and monitoring of public and private healthcare services in Dubai.²⁵

EDE, meanwhile, operates services for medical-product marketing authorization, manufacturer registration, import authorization and approval of interventional clinical studies involving medical products.²⁶

For patients, the practical lesson is simple: a clinic being licensed does not by itself prove that every product or treatment it offers has the same regulatory status.

‍

🏥 What Does a Longevity Clinic in Dubai Actually Do?

A good longevity clinic should function more like a measurement-and-decision system than a treatment menu.

The first goal is understanding where you are now.

That may include your medical and family history, existing conditions, medications, blood pressure, glucose regulation, lipids, body composition, fitness, sleep, nutrition, symptoms and age-appropriate preventive screening.

More advanced programs may add:

• VO₂max or other performance testing
• genetic or polygenic-risk testing
• epigenetic or biological-age testing
• continuous glucose monitoring
• microbiome analysis
• advanced imaging
• wider biomarker panels
  ‍

The value comes from what happens after the data are collected.

If your cardiovascular risk is elevated, what changes?

If aerobic fitness is poor, what intervention follows?

If your biological-age result improves six months later, does that change anything clinically meaningful?

A clinic measuring 200 biomarkers is not automatically providing better longevity medicine than one measuring 20 carefully selected markers.

The better question is:

What are we measuring, why does it matter, and what decision will change because of the result?

‍

👤 Who Might Benefit From a Longevity Assessment?

Longevity medicine may be most useful when it brings structure to preventive care that is currently fragmented.

Someone entering midlife with a strong family history of cardiovascular disease, metabolic risk, declining fitness, poor sleep or multiple unanswered health questions may benefit from evaluating those risks together.

A busy executive with years of disconnected annual blood tests might benefit from a physician-led assessment that turns those results into clear priorities and follow-up.

Someone considering expensive biohacking, peptide or regenerative treatments may discover that their largest opportunities are much more conventional.

And a healthy person may benefit from discovering that they do not need an extensive list of new interventions.

That can be a valuable result too.

Longevity medicine is not automatically useful because more tests or treatments are available.

Its value depends on whether it helps you make better decisions.

‍

🔬 What Should a Good Longevity Assessment Measure?

The strongest starting point is usually the least glamorous one: known drivers of disease, disability and functional decline.

Cardiovascular and metabolic health deserve substantial attention because blood pressure, lipids, glucose regulation, smoking, physical inactivity and excess adiposity influence several major chronic diseases.

Physical capacity matters too.

A 2024 overview of meta-analyses representing more than 20.9 million observations found cardiorespiratory fitness consistently associated with lower mortality and chronic-disease risk.

Across analyses, each 1-MET higher level of fitness was associated with approximately 11–17% lower all-cause mortality risk.

Because the underlying evidence was observational, this should not be interpreted as proof that deliberately gaining one MET automatically causes that exact reduction.⁴

Still, the comparison is revealing.

A VO₂max assessment and an intelligently designed exercise program may appear much less futuristic than an IV infusion or peptide protocol, yet fitness has far deeper human outcome evidence.

Body composition, muscle strength, mobility, sleep, mental health, nutrition and bone health may also deserve attention depending on the person's age and risk profile.

‍

📊 Which Longevity Interventions Have the Strongest Evidence?

The interventions that sound most advanced are not necessarily the interventions with the strongest evidence for keeping people healthy and functional.

A 2026 systematic review specifically searched for randomized controlled trials assessing multidimensional human healthspan.

Only 15 studies involving 4,656 participants met its criteria.

Eleven reported improvements from exercise or multidomain interventions containing an exercise component.

The authors could not draw firm conclusions about most other interventions because the evidence was too limited and heterogeneous.³

Nutrition provides another useful comparison.

The corrected PREDIMED trial included 7,447 adults at high cardiovascular risk and evaluated major cardiovascular events, including heart attack, stroke and cardiovascular death, rather than relying on a proprietary wellness score or aging biomarker.⁵

That distinction should guide how patients evaluate longevity claims.

A treatment that changes a biomarker may be interesting. A treatment that changes meaningful clinical outcomes is supported by a different level of evidence.

‍

🪜 STEMCIERGE Longevity Evidence Ladder

This framework is not intended to dismiss innovation.

It means the confidence of the claim should match the maturity of the evidence.

‍

🧪 What Is Biological Age, and Are Biological-Age Tests Worth It?

Biological-age tests attempt to estimate how quickly or slowly aspects of your biology appear to be aging compared with your chronological age.

They may provide useful information, but they cannot currently tell you exactly how many years you will live.

Tests may use DNA methylation, telomere length, blood chemistry, physiological variables or combinations of biomarkers.

A 2025 systematic review of 56 studies concluded that there is still no consensus gold standard for measuring biological age.⁶

A separate Nature Medicine review emphasized that biomarkers of aging still require systematic validation before they can reliably be translated into clinical decision-making or surrogate endpoints for longevity interventions.⁷

‍

🧬 Why Can Different Aging Clocks Give Different Results?

The CALERIE trial provides a useful example.

In 220 adults without obesity, two years of caloric restriction produced a modest slowing in DunedinPACE, a DNA-methylation measure designed to estimate the pace of biological aging.

However, the same intervention did not significantly alter the PhenoAge or GrimAge estimates.⁸

The treatment effects were small, and the researchers noted that definitive proof of the geroscience hypothesis would ultimately require long-term outcomes such as chronic disease and mortality.

The distinction also matters when comparing prices.

Our Dubai pricing review found standalone biological-age tests publicly advertised at roughly AED 2,000–4,500 (about US$545–$1,225).²⁴

But those products use different methodologies.

A telomere-length test and a DNA-methylation clock should not be treated as equivalent simply because both produce a number called “biological age.”

‍

🩻 Is More Testing Always Better?

No. Advanced testing is most valuable when it answers a question that is likely to change care.

More information can sometimes improve decisions.

It can also uncover incidental findings, create anxiety, trigger unnecessary follow-up or produce expensive data with no clear action attached.

Whole-body MRI illustrates the problem.

The American College of Radiology states that there is insufficient evidence to recommend routine total-body MRI screening for asymptomatic people without relevant risk factors or family history.

It also warns that nonspecific findings can lead to additional tests, procedures and expense without demonstrated health benefit.¹⁴

Compare that with coronary artery calcium scoring.

ACC/AHA guidance describes CAC as a decision aid that can refine cardiovascular-risk discussions in selected adults when treatment decisions remain uncertain.

It is specifically not intended as universal screening for everyone.¹⁵

The difference is not simply how advanced the technology appears.

It is whether the result can change a meaningful decision.

‍

🦠 What About Microbiome Testing?

The human microbiome is a serious scientific field.

However, an international 2025 consensus statement concluded that evidence supporting the clinical usefulness of many commercially available microbiome tests remains scarce, despite increasing direct-to-consumer availability.¹⁶

‍

🧬 What About Genetic and Polygenic-Risk Testing?

Genomic tools are promising, but their clinical value depends on the disease, population, quality of the underlying data and whether the result changes prevention or treatment.

A 2025 European Society of Cardiology consensus statement noted that current ESC guidelines do not recommend routine polygenic-risk-score use in clinical practice, although the technology has potential and is increasingly commercially available.¹⁷

‍

📈 What About Continuous Glucose Monitoring?

CGM is an established medical technology for diabetes and is recommended in the 2026 ADA Standards of Care for many people with diabetes where it assists management.¹⁸

That does not establish that continuous glucose monitoring improves longevity in every metabolically healthy person who wants to “optimize” glucose.

‍

💧 Does NAD+ Therapy Slow Aging?

NAD+ is biologically important and actively studied in aging research, but there is currently insufficient human evidence to conclude that IV NAD+ slows aging or extends healthspan.

Nicotinamide adenine dinucleotide, or NAD+, plays central roles in cellular metabolism.

Because NAD-related biology changes with age, researchers have explored whether increasing NAD availability could affect age-related physiology.

A 2026 systematic review identified 113 eligible studies, including 33 human interventions.

Oral NAD precursors such as nicotinamide riboside and nicotinamide mononucleotide consistently altered NAD-related biomarkers, showing clear biological activity.

However, effects on physical, metabolic, vascular and other healthspan-related outcomes in humans were heterogeneous and often null or endpoint-specific.

Most importantly for patients considering NAD IV therapy in Dubai, the review found no eligible clinical outcomes trials of IV or IM NAD+ itself for anti-aging or wellness indications.⁹

So two things can be true at once:

NAD biology is scientifically interesting.

IV NAD+ has not been proven to extend human healthspan.

Commercial adoption has moved faster than the outcomes evidence.

Our current Dubai pricing dataset includes publicly advertised NAD+ infusions from approximately AED 950 (about US$260) to AED 5,000 (about US$1,360) per session, depending on dose and provider.²⁴

‍

🧫 What About Peptide Therapy for Longevity?

“Peptide therapy” is a category, not one standardized treatment.

Individual peptides can have very different mechanisms, medical uses, evidence, safety profiles and regulatory status.

This makes blanket statements such as “peptides work” or “peptides are unsafe” unhelpful.

Dubai longevity and optimization programs may advertise compounds such as BPC-157, CJC-1295, ipamorelin, GHK-Cu or other peptides.

Some peptide medicines have established medical indications.

Others promoted for recovery, performance or healthy aging have much less human evidence.

The U.S. FDA has identified limited human safety data or other potential safety concerns for several compounds seen in the compounding market, including BPC-157, CJC-1295, injectable GHK-Cu and ipamorelin.¹⁰

For example, FDA states that available clinical data for CJC-1295 are limited and that it lacks sufficient safety information for several proposed compounded peptide uses.

Dubai is also actively tightening oversight of this category.

DHA issued Circular CIR-2026-00000107, “Regulations for Handling Peptide Products in Healthcare Facilities,” on July 29, 2026.

A September 2026 DHA workshop was specifically designed to improve awareness among healthcare facilities and professionals about proper regulatory handling of peptides in Dubai.¹¹

The detailed operative attachment to the July circular was not publicly retrievable during our research.

We therefore do not infer whether an individual peptide is legally permitted or prohibited from the circular title alone.

A peptide being advertised in Dubai does not mean every formulation, supplier, indication or prescribing pathway has the same regulatory status.

Our Dubai pricing dataset contains clinic-based or physician-mediated peptide offerings from roughly AED 1,000 to AED 4,700+ (about US$270–$1,285+), with other providers pricing recurring monthly protocols.²⁴

These are not equivalent services and should not be compared as though they were.

‍

⚕️ What About Hormone Optimization?

Treating a genuine endocrine condition can be evidence-based medicine. Using hormones simply because someone is aging is a different proposition.

The word optimization can make that distinction less obvious.

For testosterone, the Endocrine Society recommends diagnosing hypogonadism only when compatible symptoms or signs occur alongside unequivocally and consistently low testosterone.

It also recommends against routinely prescribing testosterone to all men aged 65 or older simply because testosterone levels are low.¹²

Menopausal hormone therapy offers another example.

Hormone therapy can be appropriate for menopausal symptoms and selected medical indications.

However, the U.S. Preventive Services Task Force recommends against using systemic hormone therapy solely for the primary prevention of chronic disease in asymptomatic postmenopausal people.

That recommendation does not apply to hormone therapy used for menopausal symptom management.¹³

The patient-level distinction is:

Treating a documented medical indication is not the same as prescribing hormones as a generalized anti-aging intervention.

A credible longevity program should explain which situation applies to you.

‍

🧬 Where Do Stem Cells and Regenerative Medicine Fit Into Longevity?

Stem-cell therapy should not be treated as a routine systemic anti-aging treatment in Dubai.

Regenerative medicine may be relevant to particular medical indications.

That is very different from giving stem cells to an otherwise healthy person for general rejuvenation.

Dubai's 2026 Standards for Stem Cell Services explicitly identify systemic stem-cell infusions for anti-aging, immune enhancement or “detoxification” among examples not permitted by DHA.

The standards also state that stem-cell use for enhancement, aesthetics or general wellness is not permitted without appropriate scientific validation and regulatory pathways.²³

This matters because regenerative medicine is sometimes marketed internationally as simply the premium end of a longevity-treatment menu.

It is not.

Cell source, manipulation, manufacturing, intended use, route of administration, clinical indication and regulatory pathway all matter.
‍

🔗 Read more → Stem Cell Therapy in Dubai (Complete Guide): Costs, Regulations & Treatment Options

‍

🧭 Which Popular Longevity Treatments Are Still Experimental?

Experimental does not necessarily mean implausible.

In some cases, the science is serious and the intervention deserves further research.

It simply has not reached the point where it should be presented as established longevity medicine.

Rapamycin shows why nuance matters.

A systematic review of 19 human studies found improvements in some age-associated physiological parameters, while other systems showed no significant effect and long-term questions remain.¹⁹

Metformin illustrates the same principle from another direction.

It is an important treatment for type 2 diabetes, yet a 2025 review highlighted growing uncertainty around earlier claims that it broadly slows human aging outside its established medical use.²⁰

Similarly, HBOT has recognized medical applications, but a systematic review concluded that evidence supporting its anti-aging applications remains limited.²¹

An umbrella review of ozone therapy published in 2026 found low or very low certainty evidence across the assessed meta-analyses.²²

Promising is not the same as proven.

‍

💰 How Much Does Longevity Medicine Cost in Dubai?

There is no useful single average price for longevity medicine in Dubai.

A preventive assessment, a biological-age test, an NAD+ infusion and a year-long concierge program are fundamentally different purchases.

STEMCIERGE's September 2026 Dubai longevity pricing review added 45 public-price records from 21 additional first-party source URLs to our STEMCIERGE Global Pricing Review.²⁴

The sample includes consultations, executive screening, broader longevity programs, memberships, biological-age testing, NAD+ IV therapy and physician-mediated peptide protocols.

‍

💳 Public Longevity Prices in Dubai

These are observed public prices, not standardized Dubai averages or treatment quotes.

Some are promotional, and the services included vary significantly. USD figures are rounded approximations.

That difference in scope matters more than the headline number.

An AED 10,000 diagnostic program and an AED 10,000 monthly concierge membership are not two prices for the same thing.

A one-off NAD+ infusion also should not be compared directly with a 12-week program containing physician review, blood testing, fitness assessment and multiple services.

‍

Already comparing longevity programs in Dubai? STEMCIERGE can help you understand what is included, which components have stronger evidence and which questions deserve clarification before you commit.

For broader international treatment pricing:

🔗 Read more → Global Stem Cell Therapy Cost: Prices by Country & Treatment

‍

🩺 What Happens During a Longevity Consultation in Dubai?

A good longevity consultation should leave you with more clarity, not simply a longer shopping list.

The process usually begins with your medical history, family history, medications, symptoms, lifestyle, goals and previous investigations.

From there, a clinician can decide which additional measurements are actually relevant.

A particularly good clinician should sometimes recommend doing less.

If almost every patient leaves with the same package of IVs, supplements, peptides and proprietary tests regardless of baseline health, it is reasonable to question how individualized the program really is.

‍

✅ How Do You Evaluate a Longevity Clinic in Dubai?

The number of technologies a clinic offers is a poor proxy for clinical quality.

A better evaluation looks at how the clinic reaches decisions.

‍

🧭 STEMCIERGE Longevity Program Evaluation Framework

Commercial overlap does not automatically make a medical recommendation inappropriate.

But patients deserve to understand the incentives surrounding expensive testing and recurring therapies.

‍

❓ What Should You Ask Before Paying for a Longevity Program?

These questions often reveal more than the technology list:

‍

🌆 Is Dubai a Good Destination for Longevity Medicine?

Dubai can be a compelling destination for sophisticated preventive health, advanced diagnostics and physician-led longevity programs, but the quality of the individual program matters far more than the destination itself.

Dubai offers unusual concentration.

Within one healthcare market, patients can access specialist medicine, advanced imaging, laboratory testing, performance assessment, personalized diagnostics, wellness services and regenerative medicine.

The new institutional emphasis on longevity may accelerate that ecosystem further.¹˒²

But abundance creates its own problem.

A clinic may provide excellent evidence-based cardiometabolic prevention alongside an emerging intervention with far weaker outcomes evidence.

Premium surroundings can make both appear equally established.

Dubai's advantage is therefore not that every available treatment is worthwhile.

Its advantage is choice, infrastructure and a rapidly developing regulatory environment.

For an informed patient, that can be valuable.

For an uninformed patient, it makes careful comparison even more important.

‍

🎯 The Bottom Line: Better Longevity Medicine Is About Better Decisions

Dubai's longevity sector is evolving unusually quickly.

The establishment of the Dubai Longevity Authority gives the category greater institutional weight.

While private providers are rapidly expanding access to advanced diagnostics, biological-age testing, precision-health programs, NAD+, peptides, hormone management and regenerative technologies.

That creates genuine opportunity.

It also makes discernment more valuable.

The strongest longevity program is unlikely to be the one offering the largest number of treatments.

A better model starts by identifying what is most likely to threaten your future health, addresses high-impact fundamentals first, uses advanced diagnostics when they can improve meaningful decisions and approaches emerging therapies with curiosity without pretending uncertainty has disappeared.

Longevity medicine should help you understand what deserves action now, what is worth monitoring and what may be better left until the evidence catches up.

If you are considering a longevity, regenerative medicine or advanced-health program in Dubai, STEMCIERGE can help you understand the landscape, compare approaches and identify the questions worth asking before you commit.

‍

‍

❓ Frequently Asked Questions About Longevity in Dubai

What is a longevity clinic?

A longevity clinic focuses on maintaining health and function as people age. Programs may combine preventive medicine, cardiovascular and metabolic risk assessment, fitness testing, body-composition analysis, advanced diagnostics, lifestyle interventions and, in some clinics, emerging therapies. There is no single standardized longevity-clinic model.
‍

Is longevity medicine regulated in Dubai?

Yes, increasingly. Dubai established the Dubai Longevity Authority in 2026, while DHA continues to regulate healthcare services, facilities and professionals, and federal regulators oversee relevant medical products.¹˒²˒²⁵˒²⁶
‍

How much does a longevity clinic cost in Dubai?

Public pricing varies widely. STEMCIERGE's September 2026 review found preventive assessments around AED 1,300–3,500 (about US$350–$950), broader programs around AED 7,500–16,450+ (about US$2,040–$4,480+), and premium memberships reaching significantly higher.²⁴ These are observed market prices, not standardized averages.
‍

What is the difference between longevity medicine and anti-aging?

Longevity medicine generally focuses on healthspan, disease prevention, function and risk reduction. Anti-aging is a broader commercial term that may also include aesthetics, hormones, IV treatments, supplements and experimental interventions.
‍

Are biological-age tests accurate?

Some biological-age measures are associated with aging-related outcomes at a population level, but there is no universally accepted gold-standard test.⁶ Different clocks can also respond differently to the same intervention.⁸ A result should therefore be treated as a biomarker estimate, not a prediction of exactly how long someone will live.
‍

Does NAD+ therapy slow aging?

NAD metabolism is scientifically relevant to aging, and oral NAD precursors can alter NAD-related biomarkers. However, meaningful human anti-aging outcomes remain uncertain. A 2026 systematic review found no eligible clinical outcomes trials of IV or IM NAD+ itself for anti-aging or wellness.⁹
‍

Are peptides proven for longevity?

Not as a category. Different peptides have different mechanisms, approved uses, evidence and safety profiles. Several compounds marketed for optimization or longevity have limited human safety or efficacy information, so the exact peptide should be evaluated individually.¹⁰
‍

Are stem cells used for longevity in Dubai?

Stem-cell therapies may be relevant to specific regulated medical applications, but DHA's 2026 standards specifically list systemic stem-cell infusions for anti-aging, immune enhancement or detoxification among examples that are not permitted.²³
‍

Can longevity medicine make you live longer?

No clinic can currently guarantee that a commercial longevity program will add a specific number of years to a healthy person's life. The more defensible goal is improving healthspan by reducing modifiable risk, preserving function, treating disease appropriately and applying emerging interventions only when the evidence and risk-benefit case justify them.
‍

‍

🔬 How STEMCIERGE Researched This Guide

This guide was developed using current Dubai legislation and regulatory materials, peer-reviewed human research, major professional guidelines and first-party provider pricing.

For pricing, STEMCIERGE expanded its UAE dataset in September 2026 with 45 additional Dubai longevity price records from 21 new first-party source URLs.

The review covered consultations, preventive screening, broader longevity programs, memberships, biological-age testing, NAD+ IV therapy and physician-mediated peptide offerings.²⁴

Prices are treated as market observations rather than standardized averages because treatment scope varies substantially between providers.

STEMCIERGE distinguishes established medical care from emerging and experimental interventions and does not infer regulatory approval from a treatment simply being advertised.

‍

📚 Medical Disclaimer

This guide is for informational and educational purposes only. It does not provide medical advice, diagnosis or treatment recommendations. Longevity tests and treatments may not be appropriate for every person, and scientific evidence, regulation, availability and pricing can change. Discuss personal medical decisions with an appropriately qualified healthcare professional and verify the regulatory status of any proposed treatment before proceeding. Medical and regulatory claims are tied directly to the cited primary sources, clinical guidelines and peer-reviewed research wherever applicable.

‍

📚 References

¹ Government of Dubai, Supreme Legislation Committee. Law No. (17) of 2026 Establishing the Dubai Longevity Authority. 2026. Official legislation

² Dubai Department of Economy and Tourism. Mohammed bin Rashid issues law establishing Dubai Longevity Authority. June 10, 2026. Official announcement

³ Zheng HT, Phyo AZZ, McCubbin C, et al. Interventions that prolong multidimensional healthspan in humans: a systematic review of randomized controlled trials. J Gerontol A Biol Sci Med Sci. 2026;81(7). doi:10.1093/gerona/glag133. PubMed record

⁴ Lang JJ, Prince SA, Merucci K, et al. Cardiorespiratory fitness is a strong and consistent predictor of morbidity and mortality among adults: an overview of meta-analyses representing over 20.9 million observations from 199 unique cohort studies. Br J Sports Med. 2024;58(10):556–566. doi:10.1136/bjsports-2023-107849. PubMed record

⁵ Estruch R, Ros E, Salas-Salvadó J, et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N Engl J Med. 2018;378(25):e34. doi:10.1056/NEJMoa1800389. PubMed record

⁶ Zurbuchen R, von Däniken A, Janka H, von Wolff M, Stute P. Methods for the assessment of biological age: A systematic review. Maturitas. 2025;195:108215. doi:10.1016/j.maturitas.2025.108215. PubMed record

⁷ Moqri M, Herzog C, Poganik JR, et al. Validation of biomarkers of aging. Nat Med. 2024;30:360–372. doi:10.1038/s41591-023-02784-9. Nature Medicine

⁸ Waziry R, Ryan CP, Corcoran DL, et al. Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial. Nat Aging. 2023;3(3):248–257. doi:10.1038/s43587-022-00357-y. PubMed record

⁹ Gallagher C, Emmanuel OO. NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. Ageing Res Rev. 2026;116:103057. doi:10.1016/j.arr.2026.103057. PubMed record

¹⁰ U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. Updated 2026. FDA guidance and safety information

¹¹ Dubai Health Authority. Regulations for Handling Peptide Products in Healthcare Facilities. Circular CIR-2026-00000107, July 29, 2026; subsequent regulatory-awareness workshop notice, September 10, 2026. DHA circulars register

¹² Endocrine Society. Testosterone Therapy for Hypogonadism Guideline Resources. Clinical practice guideline

¹³ U.S. Preventive Services Task Force. Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions. 2022. USPSTF recommendation

¹⁴ American College of Radiology. ACR Statement on Screening Total Body MRI. 2023. ACR statement

¹⁵ Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. J Am Coll Cardiol. 2019;74(10):e177–e232. doi:10.1016/j.jacc.2019.03.010. JACC guideline

¹⁶ Porcari S, Mullish BH, Asnicar F, et al. International consensus statement on microbiome testing in clinical practice. Lancet Gastroenterol Hepatol. 2025;10(2):154–167. doi:10.1016/S2468-1253(24)00311-X. PubMed record

¹⁷ Schunkert H, Di Angelantonio E, Inouye M, et al. Clinical utility and implementation of polygenic risk scores for predicting cardiovascular disease: a clinical consensus statement. Eur Heart J. 2025;46(15):1372–1383. doi:10.1093/eurheartj/ehae649. PubMed record

¹⁸ American Diabetes Association Professional Practice Committee. 7. Diabetes Technology: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S150–S165. doi:10.2337/dc26-S007. Diabetes Care guideline

¹⁹ Lee DJW, Hodzic Kuerec A, Maier AB. Targeting ageing with rapamycin and its derivatives in humans: a systematic review. Lancet Healthy Longev. 2024;5(2):e152–e162. doi:10.1016/S2666-7568(23)00258-1. PubMed record

²⁰ Keys MT, Hallas J, Miller RA, Suissa S, Christensen K. Emerging uncertainty on the anti-aging potential of metformin. Ageing Res Rev. 2025;111:102817. doi:10.1016/j.arr.2025.102817. PubMed record

²¹ Fisher SM, Sherif RD, Borab ZM, Kumar NG, Rohrich RJ. Hyperbaric Oxygen Therapy in Aesthetic Medicine and Anti-Aging: A Systematic Review. Aesthetic Plast Surg. 2025;49(9):2534–2544. doi:10.1007/s00266-024-04553-6. PubMed record

²² Cacciatore S, Abbatecola G, Calvani R, Veronese N. Effectiveness and Safety of Ozone Therapy in Humans: An Umbrella Review of Systematic Reviews with Meta-Analyses of Randomized Clinical Trials. Med Sci. 2026;14(2):289. doi:10.3390/medsci14020289. PubMed record

²³ Dubai Health Authority. Standards for Stem Cell Services, Version 1. Issue date December 31, 2025; effective February 28, 2026. DHA standards PDF

²⁴ STEMCIERGE. Global Pricing Master: Dubai/UAE Longevity Pricing Review. Updated September 11, 2026. Proprietary dataset. The September expansion added 45 Dubai price observations from 21 additional first-party source URLs covering consultations, screening, longevity programs, memberships, biological-age testing, NAD+ IV therapy and physician-mediated peptide protocols.

²⁵ Dubai Health Authority. About Dubai Health Authority. DHA's mandate includes regulation, licensing and monitoring of healthcare services and facilities in Dubai. DHA regulatory mandate

²⁶ Emirates Drug Establishment. Medical product regulatory services and legislation. EDE administers medical-product authorization, manufacturer registration, import and clinical-study approval functions at the UAE federal level. EDE services

‍